The angiotensin‐converting enzyme insertion/deletion and the endothelin ‐134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis
- 18 September 2007
- journal article
- Published by Wiley in Experimental Dermatology
- Vol. 16 (12), 993-998
- https://doi.org/10.1111/j.1600-0625.2007.00620.x
Abstract
Background: Psoriasis is a common chronic inflammatory skin disease. Vasoactive peptides such as endothelin‐1 (ET‐1) and bradykinin have previously been implicated in the pathogenesis of chronic plaque psoriasis. The angiotensin‐converting enzyme (ACE) gene carries a 287‐base pair insertion/deletion (I/D) gene polymorphism, which is associated with plasma concentrations of bradykinin‐degrading ACE. A functional polymorphism (EDN1 ‐134 3A/4A) in the gene encoding ET‐1 has been shown to affect ET‐1 expression. The purpose of the present study was thus to investigate a hypothesized association between these gene polymorphisms and the presence of chronic plaque psoriasis. Methods: The present case‐control study comprised 207 patients with chronic plaque psoriasis (136 with early onset and 71 with late onset disease) and 182 control subjects. Genotypes of EDN1 and ACE were determined by a 5′ exonuclease assay (Taqman). Results: The prevalence of the homozygous ACE II genotype was significantly higher in patients with early‐onset psoriasis than among control subjects (30.9% vs 19.2%, P = 0.016), yielding an odds ratio of 1.88 [95% confidence interval (CI): 1.12–3.15] for early‐onset disease. For late‐onset psoriasis, presence of the ACE II genotype was associated with a non‐significant odds ratio 1.54 (95% CI: 0.81–2.92). As for the EDN1 ‐134 3A/4A gene polymorphism, no significant differences in genotype distributions were found between patients with either early‐ or late‐onset psoriasis and control subjects (EDN1 ‐134 4A/4A: 9.6% in early‐onset and 5.6% late‐onset psoriasis vs 7.7% in controls; P > 0.05). Conclusions: Our data suggest that homozygosity for the ACE I allele may affect susceptibility to early‐onset psoriasis.Keywords
This publication has 50 references indexed in Scilit:
- Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in TaiwanBritish Journal of Dermatology, 2007
- Neutral endopeptidase and angiotensin‐converting enzyme – key enzymes terminating the action of neuroendocrine mediatorsExperimental Dermatology, 2004
- The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosisThrombosis and Haemostasis, 2004
- Functional significance of a hereditary adenine insertion variant in the 5???-UTR of the endothelin-1 genePharmacogenetics, 2003
- The Effect of Endothelin-1 on Nuclear Factor Kappa B in MacrophagesBiochemical and Biophysical Research Communications, 2001
- Identification of the ETA Receptor Subtype That Mediates Endothelin-Induced Autocrine Proliferation of Normal Human KeratinocytesBiochemical and Biophysical Research Communications, 1995
- Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasisJournal of the American Academy of Dermatology, 1993
- Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.Hypertension, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Angiotensin-converting enzyme: new concepts concerning its biological roleBiochemistry, 1989